Pelvic exenteration for cervix cancer: Would additional intraoperative interstitial brachytherapy improve survival?

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 1, 1997, Pages 143-148

  Beitler, Jonathan Jay ^a   Anderson, Patrick S ^a   Wadler, Scott ^a   Runowicz, Carolyn D ^a   Hayes, Mary Katherine ^b   Fields, Abbie L ^a   Sood, Brij ^a   Goldberg, Gary L ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Brachytherapy; Cervix cancer; Lymphovascular involvement; Margins; Pelvic exenterations; Perineural invasion

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; METASTASIS; MORTALITY; PELVIS EXENTERATION; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

EID: 0031128212     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00585-8     Document Type: Article

References (23)

1. 1. Averette, H. E.; Lichtinger, M.; Sevin, B.-U.; Girtanner, R. E. Pelvic exenteration: A 15-year experience in a general metropolitan hospital. Am. J. Obstet. Gynecol. 150:179-184; 1984.
2. 2. Brennan, M. F.; Hilaris, B.; Shiu, M. H.; Lane, J.; Magill, G.; Friedrich, C.; Hajdu, S. I. Local recurrence in adult soft-tissue sarcoma. Arch. Surg. 122:1289-1293; 1987.
3. 3. Burghardt, E.; Pickel, H.; Haas, J.; Lahousen, M. Prognostic factors and operative treatment of Stage IB to IIB cervical cancer. Am. J. Obstet. Gynecol. 156:988-996; 1987.
4. 4. Burke, T. W.; Hoskins, W. J.; Heller, P. B.; Bibro, M. C.; Weiser, E. B.; Park, R. C. Prognostic factors associated with radical hysterectomy failure. Gynecol. Oncol. 26:153-159; 1987.
5. 5. Coia, L.; Won, M.; Lanciano, R.; Marcial, V. A.; Martz, K.; Hanks, G. The patterns of care outcome study for cancer of the uterine cervix. Cancer 66:2451-2456; 1990.
6. 6. Coleman, R. L.; Keeney, E. D.; Freedman, R. S.; Burke, T. W.; Eifel, P. J. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy. Gynecol. Oncol. 55:29-35; 1994.
7. 7. Disaia, P. J.; Creasman, W. T. Clinical gynecologic oncology, 3rd ed., St. Louis: C. V. Mosby; 1989:122-123.
8. 8. Eifel, P. J.; Burke, T. W.; Delclos, L.; Wharton, J. T.; Oswald, M. J. Early stage I adenocarcinoma of the uterine cervix: Treatment results in patients with tumors 4 cm in diameter. Gynecol. Oncol. 41:199-205; 1991.
9. 9. Hockel, M.; Baussmann, E.; Mitze, M.; Knapstein, P. G. Are pelvic side-wall recurrences of cervical cancer biologically different from central relapses? Cancer 74:648-655; 1994.
10. 10. Hockel, M.; Hamm, H.; Knapstein, P. G.; Schlenger, K. Five-year experience with the Combined Operative and Radiotherapeutic Treatment (CORT) of recurrent gynecologic tumors infiltrating the pelvic wall. Gynecol. Oncol. 60:98; 1996.
11. 11. Hockel, M.; Knapstein, P. G. The combined operative and radiotherapeutic treatment (CORT) of recurrent tumors infiltrating the pelvic wall: First experience with 18 patients. Gynecol. Oncol. 46:20-28; 1992.
12. 12. Hockel, M.; Knapstein, P. G.; Kutzner, J. A novel combined operative and radiotherapeutic treatment approach for recurrent gynecologic malignant lesions infiltrating the pelvic wall. Surg. Gynecol. Obstet. 173:297-302; 1991.
13. 13. Hoskins, W. J. Prognostic factors for risk of recurrence in Stages Ib and IIa cervical cancer. Baillieres Clin, Obstet. Gynaecol. 2:817-828; 1988.
14. 14. Morley, G. W.; Hopkins, M. P.; Lindenauer, S. M.; Roberts, J. A. Pel vix exenteration, University of Michigan: 100 patients at 5 years. Obstet. Gynecol. 74:934-943; 1989.
15. 15. Parker, S. L.; Tong, T.; Bolder, S.; Wingo, P. A. Cancer Statistics 1996. CA 46:5-28; 1996.
16. 16. Parkin, D. M.; Pisani, P.; Ferlay, J. Estimates of the worldwide mortality from 18 major cancers in 1985. Int. J. Cancer 54:594-606; 1993.
17. 17. Perez, C. A.; Grigsby, P. W.; None, S. M., et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 69:2796-2806; 1992.
18. 18. Pisters, P. W. T.; Harrison, L. B.; Leung, D. H. Y.; Woodruff, J. M.; Casper, E. S.; Brennan, M. F. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J. Clin. Oncol. 14:859-868; 1996.
19. 19. Rotman, M.; Pajak, T. F.; Choi, K.; Clery, M.; Marcial, V.; Grigsby, P. W.; Cooper, J.; John, M. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB, and bulky IB and IIA cervical carcinomas: Ten year results of RTOG 79-20. JAMA 274:387-393; 1995.
20. 20. Rutledge, F. N.; Smith, J. P.; Wharton, J. T.; O'Quinn, A. G. Pelvic exenteration; Analysis of 296 patients. Am. J. Obstet. Gynecol. 129:881-892; 1977.
21. 21. Shingleton, H. M.; Soong, S.-J.; Gelder, M. S.; Hatch, K. D.; Baker, V. V.; Austin, J. M. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet. Gynecol. 73:1027-1034; 1989.
22. 22. Stehman, F. B.; Bundy, B. N.; DiSaia, P. J.; Keys, H. M.; Larson, J. E.; Fowler, W. C. Carcinoma of the cervix treated with radiation therapy. A multivariate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67:2776-2785; 1991.
23. 23. van Nagel, J. R.; Donaldson, E. S.; Wood, E. G.; Parker, J. C. The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer. Cancer 41:228-234; 1978.